Serial radionuclide assessment of doxorubicin cardiotoxicity in cancer patients with abnormal baseline resting left ventricular performance

[1]  S. Wallace,et al.  Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. , 1982, Annals of internal medicine.

[2]  Berger Hj,et al.  Nuclear cardiology (second of two parts). , 1981 .

[3]  Berger Hj,et al.  Nuclear cardiology (first of two parts). , 1981, The New England journal of medicine.

[4]  G. Cohen,et al.  Pericardial disease in patients with cancer: The differentiation of malignant from idiopathic and radiation-induced pericarditis☆ , 1981 .

[5]  I. Murray,et al.  Radionuclide ejection fraction in doxorubicin cardiotoxicity. , 1981, Cancer treatment reports.

[6]  Michael V. Green,et al.  Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. , 1981, Annals of internal medicine.

[7]  W. Roberts,et al.  Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. , 1981, The American journal of medicine.

[8]  N. Clinthorne,et al.  Myocardial imaging with a radioiodinated norepinephrine storage analog. , 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  R H Jones,et al.  Effect of age on the response of the left ventricular ejection fraction to exercise. , 1980, The New England journal of medicine.

[10]  J. Ritchie,et al.  Anthracycline cardiotoxicity: Clinical and pathologic outcomes assessed by radionuclide ejection fraction , 1980, Cancer.

[11]  Michael V. Green,et al.  Identification of subclinical cardiac abnormality 5–15 Yrs. After therapeutic mediastinal irradiation , 1980 .

[12]  M. M. Applefeld,et al.  Cardiac disease in patients who have malignancies. , 1980, Current problems in cardiology.

[13]  P. Gazes,et al.  The management of congestive heart failure. , 1980, Current problems in cardiology.

[14]  D. V. Von Hoff,et al.  Risk factors for doxorubicin-induced congestive heart failure. , 1979, Annals of internal medicine.

[15]  R. Matthay,et al.  First-pass radionuclide assessment of right and left ventricular performance in patients with cardiac and pulmonary disease. , 1979, Seminars in nuclear medicine.

[16]  L. Goldman,et al.  Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography. , 1979, The New England journal of medicine.

[17]  G. Kopelson,et al.  The etiologies of coronary artery disease in cancer patients. , 1978, International journal of radiation oncology, biology, physics.

[18]  John T. Fallon,et al.  Case 20-1978 , 1978 .

[19]  B. Zaret,et al.  Variability in sequential measures of left ventricular performance assessed with radionuclide angiocardiography. , 1978, The American journal of cardiology.

[20]  J. Mason,et al.  Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. , 1978, Annals of internal medicine.

[21]  R. Marshall,et al.  Assessment of Cardiac Performance with Quantitative Radionuclide Angiocardiography: Sequential Left Ventricular Ejection Fraction, Normalized Left Ventricular Ejection Rate, and Regional Wall Motion , 1977, Circulation.

[22]  R. Benjamin,et al.  Adriamycin cardiomyopathy—risk factors , 1977, Cancer.

[23]  R. Slavin,et al.  Pathology of high dose intermittent cyclophosphamide therapy. , 1975, Human pathology.

[24]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[25]  R. Benjamin,et al.  Adriamycin chemotherapy—efficacy, safety, and pharmacologic basis of an intermittent single high‐dosage schedule , 1974, Cancer.

[26]  J. Pitha,et al.  A clinicopathologic analysis of adriamycin cardiotoxicity , 1973, Cancer.

[27]  L. F. Fajardo,et al.  Radiation-induced heart disease. Clinical and experimental aspects. , 1971, Radiologic clinics of North America.

[28]  W. Roberts,et al.  The heart in acute leukemia. A study of 420 autopsy cases. , 1968, The American journal of cardiology.

[29]  E. W. Hancock,et al.  HEART DISEASE FOLLOWING RADIATION , 1967, Medicine.